Skip to main content

Table 1 Patients, tumors and treatment characteristics

From: Are treatment plans optimized on the basis of acuros XB dose calculation robust against anatomic changes during online adaptive radiotherapy for lung cancer regarding dose homogeneity?

Gender

 Female

4

 Male

6

Age

 Median (years)

73

 Range (years)

48–82

TNM-Stage classification, 8th edition

 IIb

1

 IIIa

5

 IIIb

3

 IIIC

1

Primary tumor site

 Upper lobe

4

 Central

2

 Lower lobe

4

Performance status

 ECOG 0

1

 ECOG 1

8

 ECOG 2

1

COPD

 Grade 0–1

6

 Grade 2

4

Response to induction treatment

 CR

1

 PR

6

 NC

2

 PD

1

CTV volume (ccm)

 Median

324.4

 Range

98.3–653.9

IMRT/ VMAT

 9-Field

3

 12-Field

6

 VMAT

1

Time from CBCT2 to end of treatment (min)

 Median

7.7

 Range

5.9–10.2